Tamsulosin Hydrochloride Capsule
Product Images NDC 72865-350

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Tamsulosin Hydrochloride (NDC 72865-350). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Xlcare Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

0.4mg 500s (0.4mg 500s)

Label for tamsulosin hydrochloride capsules, USP 0.4 mg by XL Care Pharmaceuticals, Inc. The label indicates an oral dosage form with 500 capsules per container. Storage instructions include keeping at 25°C (77°F) with excursions permitted between 15° to 30°C (59° to 86°F). Manufactured by Ascent Pharmaceuticals, Inc. and labeled for XL Care Pharmaceuticals, Inc. Includes cautionary storage and dispensing instructions.*

FDA Label Image

0.4mg 90s (0.4mg 90s)

Label for Tamsulosin Hydrochloride Capsules USP 0.4 mg by XLCare Pharmaceuticals, Inc. The package contains 90 oral capsules. The label includes storage instructions, dosage note advising to read prescribing information, and manufacturer details for Ascent Pharmaceuticals, Inc. It is marked Rx Only.*

FDA Label Image

Figure 1 (Image 02)

A line graph showing plasma concentration (ng/mL) of tamsulosin hydrochloride over time (hours) comparing fasting and fed conditions. Plasma concentration peaks earlier and higher under fasting conditions compared to fed, with both curves declining over a 36-hour period.*

FDA Label Image

Figure 2a (Image 03)

A line graph displaying the mean change over duration of treatment (weeks) for three groups: 0.8 mg, 0.4 mg, and placebo. The x-axis shows weeks of treatment from baseline to 13 weeks and LOCF, while the y-axis indicates mean change values. Three distinct lines with different markers represent each treatment group.*

FDA Label Image

Figure 2b (Image 04)

A line graph depicting mean change over duration of treatment in weeks. It compares three groups labeled as 0.8 mg, 0.4 mg, and Placebo. The x-axis represents treatment duration from 0 to 13 weeks, and the y-axis represents mean change values declining from 0 to -8. Sample sizes at different time points are noted below the x-axis. The graph includes a legend with symbols for each treatment group.*

FDA Label Image

Figure 3a (Image 05)

A line graph comparing mean change in flow rate (mL/sec) over treatment duration in weeks for three groups: 0.8 mg, 0.4 mg, and placebo. The y-axis represents mean change, and the x-axis shows duration from 0 to 13 weeks and beyond. The graph includes sample sizes for each time point and treatment group.*

FDA Label Image

Figure 3b (Image 06)

A line graph depicting mean change in an unspecified measurement (mL/sec) over the duration of treatment in weeks. The graph compares treatments with tamsulosin hydrochloride at 0.4 mg and 0.8 mg doses and a placebo, showing trends for each group over 13 weeks plus a last observation carried forward (LOCF) data point.*

FDA Label Image

Structural Formula (Structural Formula)

Chemical structure of tamsulosin hydrochloride, showing its molecular arrangement including aromatic rings, ether linkages, amine, sulfonamide groups, and the hydrochloride component.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.